To examine if CD44 merely serves as a marker of CSCs or plays a role in conferring CSCs traits to cancer cells, Zhang and colleagues showed that CD44s is strongly expressed in CSCs, and by knocking down CD44, the tumorigenicity of cancer cells was greatly reduced, with a concomitant downregulation of CD44 expression in these cells. The gene discussed is CD44; the disease is cancer.